Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shanghai Zhaxin Integrated Traditional Chinese and Western Medicine Hospital is a specialized private medical facility in Shanghai, China, dedicated to the treatment of hematological disorders and cancers. As a member of the GoBroad Healthcare Group, the hospital combines advanced Western medical techniques, such as hematopoietic stem cell transplantation (HSCT) and CAR-T cell therapy, with Traditional Chinese Medicine to optimize patient outcomes. It serves as a significant clinical research site, conducting numerous trials for innovative cellular immunotherapies targeting leukemia, lymphoma, and multiple myeloma. The hospital is equipped with state-of-the-art diagnostic labs and specialized hematology wards, providing comprehensive care for both adult and pediatric patients with complex blood diseases. Its integration of clinical care and research makes it a key player in the Chinese hematology landscape.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shanghai Zhaxin Integrated Traditional Chinese and Western Medicine Hospital.